drugset / Trial / NCT02854371
Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI
Phase 4
Completed
54 enrolled
Seoul National University Hospital
National Research Foundation of Korea · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Liver function is a key factor that can help predict the clinical outcome in patients with cirrhosis. Traditionally, liver function was measured using either indocyanine green (ICG) or other radionucleotides. Recently, gadoxetic acid has been reported to show liver function in several studies. There have been several approaches to measure liver function using gadoxetic acid, and hepatocyte fraction is one of the promising methods. Since gadoxetic acid enhanced liver MRI is clinically used world widely, it would be valuable if we can measure liver function using hepatocyte fraction.
Timeline
- Start
- 2016-08
- Primary completion
- 2017-02
- Completion
- 2018-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GADOXETIC ACID | Diagnostic / imaging agent | 0.025 unknown | Intravenous |